Class IITerminatedD-1086-2019
Drug recall · April 17, 2019
SODIUM CHLORIDE PRES-FREE 5% OPHTH STERILE* SOLUTION. 20ml eye drops recall
Why: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
SODIUM CHLORIDE PRES-FREE 5% OPHTH STERILE* SOLUTION. 20ml eye drops, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330
- Lots / codes
Lot: 12022019@30, distributed between 09-01-2018 to 02-20-2019.
- Quantity
- 1 prescription 20ml solution
- Company
- Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy, Corvallis, OR
- Distribution
- Dispensed in Oregon
- Initiated
- February 21, 2019 · Voluntary: Firm initiated
- Classified
- April 9, 2019
- Reported
- April 17, 2019
- Ended
- July 23, 2020
- How notified
- Telephone
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IITerminatedApr 17, 2019DEXAMETHASONEHealth Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy · D-1087-2019Class IITerminatedApr 17, 2019ACETYL-L-CYSTEINE 10% P.F. OPHTH SOLUTIONHealth Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy · D-1088-2019Class IITerminatedApr 17, 2019HYDROXYPROGESTERONE CAPROATE 250 MG/ML OIL* INJECTABLEHealth Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy · D-1089-2019Class IITerminatedApr 17, 2019PAPAVERINE-PHENTOLAMINE-PGE1 22-0.8 MG-8 MCG/ML* INJECTABLEHealth Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy · D-1090-2019Class IITerminatedApr 17, 2019PGE1 40 MCG/ML* INJECTABLEHealth Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy · D-1091-2019Class IITerminatedApr 17, 2019PAPAVERINE-PHENTOLAMINE 30-1 MG/ML* INJECTABLEHealth Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy · D-1092-2019Class IITerminatedApr 17, 2019PAPAVERINE-PHENTOLAMINE-PGE1 30-1 MG-10 MCG/ML* INJECTABLEHealth Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy · D-1093-2019Class IITerminatedApr 17, 2019PAPAVERINE-PHENTOLAMINE-PGE1 12-1MG-10MCG/ML INJECTABLEHealth Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy · D-1094-2019Class IITerminatedApr 17, 2019PAPAVERINE-PHENTOLAMINE-PGE1 17.16-0.57MG-19.45MCG/ML* INJECTABLEHealth Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy · D-1095-2019Class IITerminatedApr 17, 2019PAPAVERINE-PHENTOLAMINE-PGE1 23-0.96MG-19.2MCG/ML INJECTABLEHealth Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy · D-1096-2019Class IITerminatedApr 17, 2019PAPAVERINE-PHENTOLAMINE-PGE1 30-1.6 MG-16 MCG/ML* INJECTABLEHealth Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy · D-1097-2019Class IITerminatedApr 17, 2019PGE1-LIDOCAINE 40 MCG-1% /ML* INJECTABLEHealth Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy · D-1098-2019
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.